speaker-icon

Latest Posts

Innoplexus-AIO-partnership

2

Jan 24

Innoplexus and AIO Studien gGmbH are jointly announcing the start of a pilot project as part of the AIO data hub initiative

January 02, 2024 - Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health...
Read More
anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
anavex_partex_partnership_Innoplexus

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience.

Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce their strategic partnership, aimed at revolutionizing the biopharma industry. By leveraging Partex’s proprietary AI (Artificial Intelligence) technology and Anavex’s innovative precision medicine drug development platform, we seek to enhance patient outcomes and reshape the future of healthcare.

Dr. Gunjan Bhardwaj, CEO of Partex NV, expressed his excitement, stating, “Together with Anavex, we embark on this impactful journey to extend our patient ecosystem. Our Life Sciences Language Processing platform with Generative Artificial Intelligence capabilities will significantly improve patient outcomes.”

Dr. Christopher Missling, PhD, President and CEO of Anavex Life Sciences, added, “We are thrilled to collaborate with Partex and fully embrace AI to expand beyond R&D into healthcare sales marketing. Our expertise in precision medicine drug development, combined with Partex’s disruptive approach, will bring better treatment options to patients in a truly patient-centric manner.”

Stay tuned for the groundbreaking advancements we’ll achieve together. Together, we are reshaping the future of biopharma.

Read more

Featured News

new_app_cancer_patients

New app for cancer patients

Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…